» Articles » PMID: 22248302

From the First Selective Non-peptide AT(2) Receptor Agonist to Structurally Related Antagonists

Overview
Journal J Med Chem
Specialty Chemistry
Date 2012 Jan 18
PMID 22248302
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A para substitution pattern of the phenyl ring is a characteristic feature of the first reported selective AT(2) receptor agonist M024/C21 (1) and all the nonpeptidic AT(2) receptor agonists described so far. Two series of compounds structurally related to 1 but with a meta substitution pattern have now been synthesized and biologically evaluated for their affinity to the AT(1) and AT(2) receptors. A high AT(2)/AT(1) receptor selectivity was obtained with all 41 compounds synthesized, and the majority exhibited K(i) ranging from 2 to 100 nM. Five compounds were evaluated for their functional activity at the AT(2) receptor, applying a neurite outgrowth assay in NG108-15 cells. Notably, four of the five compounds, with representatives from both series, acted as potent AT(2) receptor antagonists. These compounds were found to be considerably more effective than PD 123,319, the standard AT(2) receptor antagonist used in most laboratories. No AT(2) receptor antagonists were previously reported among the derivatives with a para substitution pattern. Hence, by a minor modification of the agonist 1 it could be transformed into the antagonist, compound 38. These compounds should serve as valuable tools in the assessment of the role of the AT(2) receptor in more complex physiological models.

Citing Articles

The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.

Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.

PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.


Design, synthesis and biological evaluation of novel biphenylsulfonamide derivatives as selective AT receptor antagonists.

Wang D, Zhao W, Zhang Z, Zhang Y, Li J, Huang W Front Chem. 2022; 10:984717.

PMID: 36092654 PMC: 9458978. DOI: 10.3389/fchem.2022.984717.


-Phenacyldibromobenzimidazoles-Synthesis Optimization and Evaluation of Their Cytotoxic Activity.

Kowalkowska A, Chojnacki K, Multan M, Maurin J, Lukowska-Chojnacka E, Winska P Molecules. 2022; 27(14).

PMID: 35889223 PMC: 9315981. DOI: 10.3390/molecules27144349.


High affinity rigidified AT receptor ligands with indane scaffolds.

Wallinder C, Skold C, Sundholm S, Guimond M, Yahiaoui S, Lindeberg G Medchemcomm. 2020; 10(12):2146-2160.

PMID: 32904210 PMC: 7451071. DOI: 10.1039/c9md00402e.


A Series of Analogues to the ATR Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode.

Isaksson R, Lindman J, Wannberg J, Sallander J, Backlund M, Baraldi D ChemistryOpen. 2019; 8(1):114-125.

PMID: 30697513 PMC: 6346239. DOI: 10.1002/open.201800282.